CY1109500T1 - Φαρμακευτικες συνθεσεις που περιεχουν zd6474 - Google Patents
Φαρμακευτικες συνθεσεις που περιεχουν zd6474Info
- Publication number
- CY1109500T1 CY1109500T1 CY20091101075T CY091101075T CY1109500T1 CY 1109500 T1 CY1109500 T1 CY 1109500T1 CY 20091101075 T CY20091101075 T CY 20091101075T CY 091101075 T CY091101075 T CY 091101075T CY 1109500 T1 CY1109500 T1 CY 1109500T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- diluent
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
Μια φαρμακευτική σύνθεση που περιέχει ZD6474 ή ένα φαρμακευτικώς ανεκτό άλας αυτής, ένα εύθραυστο αραιωτικό μέσo κι ένα δεύτερο αραιωτικό μέσο το οποίο είναι πρακτικά αδιάλυτο και έχει ιδιότητες όλκιμης συμπίεσης.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0411378.3A GB0411378D0 (en) | 2004-05-21 | 2004-05-21 | Pharmaceutical compositions |
| EP05744858A EP1753431B1 (en) | 2004-05-21 | 2005-05-18 | Pharmaceutical compositions comprising zd6474 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109500T1 true CY1109500T1 (el) | 2014-08-13 |
Family
ID=32607743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091101075T CY1109500T1 (el) | 2004-05-21 | 2009-10-15 | Φαρμακευτικες συνθεσεις που περιεχουν zd6474 |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US8067427B2 (el) |
| EP (1) | EP1753431B1 (el) |
| JP (1) | JP4740947B2 (el) |
| KR (1) | KR101192935B1 (el) |
| CN (1) | CN101031303B (el) |
| AR (2) | AR049059A1 (el) |
| AT (1) | ATE439841T1 (el) |
| AU (1) | AU2005244650B2 (el) |
| BR (1) | BRPI0511253B8 (el) |
| CA (1) | CA2565513C (el) |
| CY (1) | CY1109500T1 (el) |
| DE (1) | DE602005016105D1 (el) |
| DK (1) | DK1753431T3 (el) |
| ES (1) | ES2330025T3 (el) |
| GB (1) | GB0411378D0 (el) |
| HK (1) | HK1099220A1 (el) |
| HR (1) | HRP20090547T1 (el) |
| IL (1) | IL178928A (el) |
| ME (2) | ME02778B (el) |
| MX (1) | MXPA06013501A (el) |
| MY (1) | MY138868A (el) |
| NO (1) | NO338324B1 (el) |
| NZ (1) | NZ550931A (el) |
| PL (1) | PL1753431T3 (el) |
| PT (1) | PT1753431E (el) |
| RS (1) | RS51112B (el) |
| RU (1) | RU2383343C2 (el) |
| SA (1) | SA05260133B1 (el) |
| SI (1) | SI1753431T1 (el) |
| TW (1) | TWI355269B (el) |
| UA (1) | UA81732C2 (el) |
| UY (1) | UY28901A1 (el) |
| WO (1) | WO2005112934A1 (el) |
| ZA (1) | ZA200609110B (el) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2278511B1 (es) * | 2005-07-28 | 2008-06-16 | Laboratorios Almirall S.A. | Comprimidos con perfil de disolucion mejorado. |
| US11136625B2 (en) | 2013-08-28 | 2021-10-05 | Crown Bioscience, Inc. (Taicang) | Gene expression signatures predictive of subject response to a multi-kinase inhibitor and methods of using the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9718972D0 (en) * | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| AU769222B2 (en) * | 1999-11-05 | 2004-01-22 | Genzyme Corporation | Quinazoline derivatives as VEGF inhibitors |
| GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
| KR100419555B1 (ko) * | 2000-05-29 | 2004-02-19 | 주식회사유한양행 | 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자 |
| US20050119303A1 (en) | 2002-03-05 | 2005-06-02 | Eisai Co., Ltd | Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with an angiogenesis inhibitor |
-
2004
- 2004-05-21 GB GBGB0411378.3A patent/GB0411378D0/en not_active Ceased
-
2005
- 2005-05-09 TW TW094114935A patent/TWI355269B/zh active
- 2005-05-17 UY UY28901A patent/UY28901A1/es unknown
- 2005-05-18 ME MEP-2009-458A patent/ME02778B/me unknown
- 2005-05-18 ES ES05744858T patent/ES2330025T3/es active Active
- 2005-05-18 DK DK05744858T patent/DK1753431T3/da active
- 2005-05-18 CN CN2005800162448A patent/CN101031303B/zh active Active
- 2005-05-18 AT AT05744858T patent/ATE439841T1/de active
- 2005-05-18 JP JP2007517415A patent/JP4740947B2/ja active Active
- 2005-05-18 RU RU2006145357/15A patent/RU2383343C2/ru active Protection Beyond IP Right Term
- 2005-05-18 DE DE602005016105T patent/DE602005016105D1/de active Active
- 2005-05-18 RS RSP-2009/0458A patent/RS51112B/sr unknown
- 2005-05-18 BR BRPI0511253A patent/BRPI0511253B8/pt active IP Right Grant
- 2005-05-18 SI SI200530793T patent/SI1753431T1/sl unknown
- 2005-05-18 SA SA05260133A patent/SA05260133B1/ar unknown
- 2005-05-18 ME MEP-2013-50A patent/ME01505B/me unknown
- 2005-05-18 US US11/596,979 patent/US8067427B2/en active Active
- 2005-05-18 PT PT05744858T patent/PT1753431E/pt unknown
- 2005-05-18 NZ NZ550931A patent/NZ550931A/en not_active IP Right Cessation
- 2005-05-18 AU AU2005244650A patent/AU2005244650B2/en active Active
- 2005-05-18 CA CA2565513A patent/CA2565513C/en active Active
- 2005-05-18 WO PCT/GB2005/001931 patent/WO2005112934A1/en active Application Filing
- 2005-05-18 KR KR1020067026603A patent/KR101192935B1/ko active IP Right Grant
- 2005-05-18 PL PL05744858T patent/PL1753431T3/pl unknown
- 2005-05-18 EP EP05744858A patent/EP1753431B1/en active Active
- 2005-05-18 MX MXPA06013501A patent/MXPA06013501A/es active IP Right Grant
- 2005-05-18 UA UAA200613289A patent/UA81732C2/ru unknown
- 2005-05-19 MY MYPI20052271A patent/MY138868A/en unknown
- 2005-05-20 AR ARP050102087A patent/AR049059A1/es not_active Application Discontinuation
-
2006
- 2006-10-29 IL IL178928A patent/IL178928A/en active IP Right Grant
- 2006-11-01 ZA ZA200609110A patent/ZA200609110B/en unknown
- 2006-12-12 NO NO20065735A patent/NO338324B1/no not_active IP Right Cessation
-
2007
- 2007-06-13 HK HK07106372.8A patent/HK1099220A1/xx unknown
-
2009
- 2009-10-13 HR HR20090547T patent/HRP20090547T1/xx unknown
- 2009-10-15 CY CY20091101075T patent/CY1109500T1/el unknown
-
2017
- 2017-11-09 AR ARP170103128A patent/AR110045A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110419T1 (el) | Τρικυκλικες ενωσεις με βαση το 1,6-διυδρο-1,3,5,6-tetpaaza-as-ινδακενιο και φαρμακευτικες συνθεσεις που τις περιεχουν ως αναστολεις της ενζυμικης ενεργοτητας της ικκ | |
| HRP20080564T3 (en) | Dihydrotetrabenazines and pharmaceutical compositions containing them | |
| CY1116150T1 (el) | Παραγωγα οξαδιαζολης και η χρηση τους ως ενισχυτων μεταβοτροπικου υποδοχεα γλουταμικου - 842 | |
| SE0302811D0 (sv) | Novel compounds | |
| CY1118496T1 (el) | Φαρμακεyτικες συνθεσεις | |
| CY1109465T1 (el) | Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης | |
| CY1113159T1 (el) | Ανταγωνιστες υποδοχεα γλυκαγονης, παρασκευη και θεραπευτικες χρησεις | |
| CY1112886T1 (el) | Ανοσοκατασταλτικος παραγοντας ο οποιος περιλαμβανει μια ετεροκυκλικη ενωση ως δραστικο συστατικο | |
| CY1109010T1 (el) | γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ | |
| CY1107419T1 (el) | Προφαρμακα αντι-ιικων μεσων απο πιπεραζινη και υποκατεστημενη πιπεριδινη | |
| DK3311805T3 (da) | Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler | |
| CY1108797T1 (el) | Α-κρυσταλλικη μορφη του ρανελικου στροντιου, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις που την περιεχουν | |
| BRPI0417717A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| CY1105162T1 (el) | Ενωσεις και η χρηση τους ως αναστολεις 5-ητ | |
| CY1109956T1 (el) | Στερεα φαρμακευτικη συνθεση περιλαμβανουσα υδροχλωρικη ντονεπεζιλη | |
| SE0301653D0 (sv) | Novel compounds | |
| CY1109880T1 (el) | ΑΝΤΑΓΩΝΙΣΤΗΣ CaSR | |
| TW200738649A (en) | Calcilytic compounds | |
| CY1111983T1 (el) | Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο | |
| CY1115903T1 (el) | Φλουρμπιπροφαινη και μυοχαλαρωτικοι συνδυασμοι | |
| DK1511489T3 (da) | Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A | |
| DE60313350D1 (de) | Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer | |
| NO20063293L (no) | Farmasoytiske forbindelser | |
| ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
| EA200600590A1 (ru) | Фармацевтические композиции модафинила с модифицированным высвобождением |